Page 35 - Translational Sciences News Today

The FDAs vaccine advisers lent support to the agencys plan to try to simplify future COVID shots, with an aim of having many people get just one dose in the fall.

Animal testing is no longer required for new drugs, marking a triumph in scientific research and technology and animal rights activism.

Many questions remain about next steps for US vaccine policy. But the FDA advisory panel’s hearty endorsement of a single-composition COVID-19 vaccine represents a pivotal step.

A new study led by Washington University School of Medicine in St. Louis reveals at least one cause of low white blood cell counts in patients treated for glioblastoma and demonstrates a potential treatment strategy that improves survival in mice. Shown are MRI scans of a patient with this type of brain tumor.

This prospective study compares the risk of transmission of influenza virus infection among household contacts of patients with influenza during the 2021-2022 i

Two new studies add to the evidence that social isolation is a substantial risk factor for dementia in ...

This article will explore the importance of cell culture quality control and highlight recent developments in this area.

FIU College of Medicine researchers make discovery thats the first step toward cheaper, effective, easy-to-take treatments for osteoporosis and other diseases associated with bone loss.

Last year paved the way for a potential breakthrough this year for both gene-editing biotech companies.

After years of campaigning, animal rights advocates are celebrating because, finally, animal testing is no longer necessary for drug approval. However, substitutes are still unavailable.